Dr. Beth Faiman has been appointed as the Editor-in-Chief of the Journal of the Advanced Practitioner in Oncology (JADPRO), effective August 1, 2020. She succeeds Pamela Hallquist Viale, who led the journal as Editor-in-Chief of JADPRO since its founding 10 years ago.
Dr. Faiman brings extensive clinical expertise and a wealth of publishing experience to her new role. She is currently an adult nurse practitioner in the Department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic in Cleveland, Ohio.
Previously, Dr. Faiman was the editor-in-chief of The Oncology Nurse APN/PA, and she currently sits on the editorial board of ASH Clinical News, among others. She is a founding member of the International Myeloma Foundation Nurse Leadership Board. Dr. Faiman has edited several nursing and medical books, chapters, and articles, and is an active author, presenter, and educator on the topics of plasma cell dyscrasias, hematologic cancers, and cancer symptom management.
Dr. Faiman is the recipient of several awards, including the 2015 Dean’s Legacy Award for PhD Studies and the 2016 Leukemia/Lymphoma Society Woman of the Year for Cleveland/Akron Ohio. She was inducted as a Fellow in the American Academy of Nursing (FAAN) in 2019.
Dr. Faiman has a long history of association with JADPRO, going back to the journal’s first year of publication. She has been an active peer reviewer, as well as the author of several articles in the journal, publishing on such topics as new agents in multiple myeloma and symptom management for patients with cancer. Dr. Faiman has also presented at JADPRO Live, the annual educational meeting for advanced practitioners, and has been a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO) since its inception.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.